GlobeNewswire

Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
03/11/2026
- Completes planned leadership transition as Prenetics revenue is almost entirely IM8 - Prenetics’ finance leadership function now based in the United States - The Company will report third quarter 2026 results on [...]
Keto-Mojo Unveils Redesigned Homepage and New Brand Story
03/11/2026
Keto Works. You Can Do It. Keto-Mojo Unveils a Redesigned Homepage and a New Brand Story Built For Metabolic Intelligence The new http://keto-mojo.com brings the keto lifestyle, testing, recipes, research, and community [...]
New York Should Not Force Amish to Choose Between Their Faith and Their Farms, the Association of American Physicians and Surgeons Urges the Supreme Court
03/11/2026
TUCSON, Ariz., Nov. 03, 2026 (GLOBE NEWSWIRE) -- In its second recent trip to the U.S. Supreme Court, Amish in New York State seek restoration of a religious exemption from school vaccine mandates that its legislature [...]
Novo Nordisk A/S - share repurchase programme
03/11/2026
Bagsværd, Denmark, 3 November 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Ozari Health Expands Tirzepatide Compounding Pharmacy Network to Five US-Licensed 503A Pharmacies
03/11/2026
The national telehealth platform now routes compounded tirzepatide and semaglutide prescriptions to five publicly named US-licensed 503A sterile compounding pharmacies in Florida and Texas, publishes each one's location [...]
Dr. John K. Drisdale DMD, a Master of the Academy of General Dentistry, Brings Advanced Cosmetic Dentistry and Full Mouth Reconstruction to Midland, Texas
03/11/2026
Dr. John K. Drisdale, DMD, MAGD, joins fewer than 2% of general dentists in the United States and Canada who have earned Mastership in the Academy of General Dentistry. The award follows more than 1,100 hours of [...]
Humanaut Health Announces Six New Locations, Expanding Its Footprint as a National Leader in Longevity and Regenerative Medicine
03/11/2026
The rollout includes a new Stem Cell Center of Excellence in Park City, with additional clinics planned in California, Texas, Kansas City and Mexico City AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Humanaut Health [...]
QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
03/11/2026
Austrian Research Promotion Agency FFG awards funding to QUANTRO to develop and implement ASCEND, an integrated artificial intelligence platform for transcription factor drug discovery Vienna, Austria, Nov. 03, 2026 ( [...]
Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%
03/11/2026
Internet, Everywhere, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Shopify announced today financial results for the quarter ended September 30, 2026. Shopify achieved 32% revenue growth (32% in constant currency) and a 22% free [...]
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Dr. Oetker lance la cinquième édition de Giuseppe Entraîne-toi avec un pro et accueille P.K. Subban comme nouvel ambassadeur
03/11/2026
L'ancien joueur vedette de la LNH et figure bien connue des Québécois rejoint cette nouvelle édition du programme, qui célèbre les équipes de hockey mineur ayant un impact positif dans leur communauté. TORONTO, 03 nov. [...]
Dr. Oetker Launches Fifth Year of Giuseppe Practice with a Pro, Welcomes P.K. Subban as the Program’s New Ambassador
03/11/2026
The Canadian hockey icon joins the next chapter of the community-based program, celebrating minor hockey teams that are making a difference in their communities TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Dr. Oetker [...]
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
03/11/2026
Acquisition significantly expands the depth and scale of Evestia Clinical’s established medical writing capabilities for biotech innovators and pharmaceutical companies The deal expands Evestia Clinical’s European [...]
Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a [...]
Jade Biosciences to Participate in Upcoming Conferences
03/11/2026
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Rapport Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer
03/11/2026
Neil joins from Novo Nordisk and brings more than 20 years of experience in business development and strategic transactions Appointment strengthens MitoRx’s business development capabilities as the Company advances [...]
Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)
03/11/2026
— FDA clearance allows Pasithea to advance PAS-004 for NF1-associated cNF, a condition affecting over 95% of people with NF1 and for which there are currently no FDA-approved systemic therapies . — MIAMI, Nov. 03, 2026 [...]
Axsome Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum